Hereditary thrombophilic factors in stroke due to cerebral infarct

American Journal of the Medical Sciences

Volumn 337, Issue 1, 2009, Pages 11-13

  Bolaman, Zahit ^a   Ozkul, Ayca ^a   Kiylioglu, Nefati ^a   Kadikoylu, Gurhan ^a   Erturk, Ahmet ^a   Batun, Sabri ^b   Akyol, Ali ^a  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

^b DICLE UNIVERSITY   (Turkey)

Author keywords

Cerebral infarct; Hereditary; Stroke; Thrombophilic factors

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN; BLOOD CLOTTING FACTOR 5; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE MUTATION; GENETIC RISK; HEREDITY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; RISK ASSESSMENT; RISK FACTOR; SMOKING; THROMBOPHILIA; BRAIN INFARCTION; GENETICS; MIDDLE AGED; MUTATION; STROKE;

ADULT; AGED; CEREBRAL INFARCTION; FACTOR V; FEMALE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; PROTHROMBIN; STROKE;

EID: 62249195567     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181753b86     Document Type: Article

References (34)

1. Goodnight SH, Griffin JH. Hereditary thrombophilia. In: Beutler E, Lichtman MA, et al, editors. William's hematology. Mc Graw Hill, International edition; 2001. p. 1697-1714
2. De Stefano V, Finazzi G, Mannuci PM. Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood 1996;87: 3531-3544 (Pubitemid 26129579)
3. Koeleman BP, Reitsma PH, Bertina RM. Familial thrombophilia: a complex genetic disorders. Semin Hematol 1997;34:256-264 (Pubitemid 27295158)
4. Seligsohn U, Libertsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001;344:1222-1231
5. Martinelli I, Manucci PM, De Stefano V, et al. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood 1998;92:2353-2358 (Pubitemid 28452977)
6. Mandalaki-Yannitsioti T. The impact of knowledge of thrombophilia on the diagnosis and management of thrombotic disease. Haema 2002; 5:100-109
7. Longstreth WT, Rosendaal FR, Siscovick DS, et al. Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A). Stroke 1998;29:577-580
8. Sanchez-Martin B, Grasa JM, Latorre A, et al. Acquired and inherited hypercoagulability among patients with cerebral venous thrombosis [abstract]. Neurologia 2002;17:405-409 (Pubitemid 35356144)
9. Kurkowska-Jastrzebska I, Wicha W, Dowżenko A, et al. Concomitant heterozygous factor V Leiden mutation and homozygous prothrombin gene variant (G20210A) in patient with cerebral venous thrombosis. Med Sci Monit 2003;9:47-51. (Pubitemid 36713448)
10. Notsu Y, Nabika T, Park HY, et al. Evaluation of genetic risk factors for silent brain infarction. Stroke 1999;30:1881-1886 (Pubitemid 29411831)
11. Wolf PA. Epidemiology of stroke. In: Mohr JP, Choi DW, Grotta JC, editors. Stroke: pathophysiology, diagnosis, and management. 4th ed. Philadelphia: Elsevier BV Publishers; 2004. p. 13-17.
12. Bovill EG, Hasstedt SJ, Leppert MF, et al. Hereditary thrombophilia as a model for multigenic disease. Thromb Haemost 1999;344:1739-1742
13. Arima T, Motomura M, Nishiura Y, et al. Cerebral infarction in a heterozygote with variant antithrombin III. Stroke 1992;23:1822-1825
14. Kim RJ, Becker RC. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am Heart J 2003;146:948-957
15. Markus HS, Hambley H. Neurology and the blood: haematological abnormalities in ischaemic stroke. J Neurol Neurosurg Psychiatry 1998;64:150-159 (Pubitemid 28159792)
16. Catto A, Carter A, Ireland H, et al. Factor V Leiden gene mutation and thrombin generation in relation to the development of acute stroke. Arterioscler Thromb Vasc Biol 1995;15:783-785
17. Markus HS, Zhang Y, Jeffery S. Screening for the factor-V Arg 506 Gln mutation in patients with TIA and stroke. Cerebrovasc Dis 1996; 6:360-362 (Pubitemid 26373631)
18. Albucher JF, Guiraud-Chaumeil B, Chollet F, et al. Frequency of resistance to activated protein C due to factor V mutation in young patients with ischemic stroke. Stroke 1996;27:766-777 (Pubitemid 26114448)
19. De Lucia D, Cerbone AM, Belli A, et al. Resistance to activated protein C in adults with a history of juvenile transient ischemic attacks. Thromb Haemost 1996;76:627-631 (Pubitemid 26372022)
20. Landi G, Cella E, Martinelli I, et al. Arg506Gln factor V mutation and cerebral ischemia in the young. Stroke 1996;27:1697-1698 (Pubitemid 26295930)
21. Hankey GJ, Eikelboom JW, van Bockxmeer FM, et al. Inherited thrombophilia in ischemic stroke and its pathogenic subtypes. Stroke 2001;32:1793-1807
22. Morita H, Kurihara H, Tsubaki S, et al. Methylenetetrahydrofolate reductase gene polymorphism and ischemic stroke in Japanese. Arterioscler Thromb Vasc Biol 1998;18:1465-1469 (Pubitemid 28421885)
23. Lalouschek W, Schillinger M, Hsieh K, et al. Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years. Stroke 2005;36:1405-1409 (Pubitemid 40967502)
24. Aznar J, Mira Y, Vaya A, et al. Factor V Leiden and prothrombin G20210A mutations in young adults with cryptogenic ischemic stroke. Thromb Haemost 2004;91:1031-1034 (Pubitemid 38647509)
25. Meseguer E, Llamas P, Fernandez de Velasco J, et al. Prothrombotic factors in stroke [abstract]. Neurologia 2004;19:99-105.
26. Akar N, Akar E, Akcay R, et al. Effect of methylenetetrahydrofolate reductase 677 C-T, 1298 A-C and 1317 T-C on factor V 1691 mutation in Turkish deep vein thrombosis patients. Thromb Res 2000;97:163-167 (Pubitemid 30055281)
27. Agaoglu N, Turkyilmaz S, Ovali E, et al. Prevalence of prothrombotic abnormalities in patients with acute mesenteric ischemia. World J Surg 2005;29:1135-1138 (Pubitemid 41618713)
28. Ayyildiz O, Kalkanli S, Batun S, et al. Prothrombin G20210A gene mutation with lightcycler polymerase chain reaction in venous thrombosis and healthy population in the southeast of Turkey. Heart Vessels 2004;19:164-166 (Pubitemid 39149325)
29. Ucar F, Sonmez M, Ovali E, et al. MTHFR C677T polymorphism an dits relation to ischemic stroke in the Black sea Turkish population. Am J Hematol 2004;76:40-43 (Pubitemid 38579536)
30. Gurgey A, Unal S, Okur H, et al. Prothrombin G20210A mutation in Turkish children with thrombosis and the frequency of prothrombin C20209T. Pediatr Hematol Oncol 2005;22:309-314 (Pubitemid 40770482)
31. Akar N, Akar E, Deda G, et al. Factor V1691 G-A, prothrombin 20210 G-A, and methylenetetrahydrofolate reductase 677 C-T variants in Turkish children with cerebral infarct. J Child Neurol 1999;14:749-751
32. Yasa MH, Bolaman Z, Yukselen V, et al. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients. Hepatogastroenterology 2007;54: 1438-1442. (Pubitemid 47203444)
33. Shelnutt KP, Kauwell GP, Chapman CM, et al. Folate status response to controlled folate intake is affected by the methylenetetrahydrofolate reductase 677C3T polymorphism in young women. J Nutr 2003;133:4107-4111. (Pubitemid 37505484)
34. Solis C, Veenema K, Ivanov AA, et al. Folate intake at RDA levels is inadequate for Mexican American men with the methylenetetrahydrofolate reductase 677TT genotype. J Nutr 2008;138:67-72.